Skip to main content
Caplight Logo









DR.NOAH Biotech

DR.NOAH Biotech

Private
South KoreaHealthcare & Life Scienceshttps://drnoahbiotech.com/

Last Round

Series B

May 1, 2022

Total Funding Raised

$16.99M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DR.NOAH Biotech is a biotechnology company that develops innovative drug combinations for orphan diseases using its proprietary AI-driven drug discovery platform, ARK.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryAI drug discoveryorphan drugdrug combinationbiotechin silico drug discoverydrug-drug interactioncomputational biologyAI pharmatarget identificationclinical stageneurological diseasedrug repurposingbiopharmadigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DR.NOAH Biotech Comparables

Compare DR.NOAH Biotech with similar companies based on industry and business-model similarity.

DR.NOAH Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healx
87%
Arontier
85%
PharmCADD Co., Ltd.
84%

DR.NOAH Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2022
StrategicNov 1, 2020
Series AAug 12, 2020
Pre SeedDec 1, 2018

Key People

Founding team and executive leadership

Ji-hyun Lee

CEO

Executive Team

DR.NOAH Biotech Investors

Notable investors and investment history

DR.NOAH Biotech investors
InvestorRounds
BNH INVESTMENTPre Seed, Series A
CKD Venture CapitalSeries B
KB InvestmentSeries A
Pathfinder HSeries B
L&S Venture CapitalSeries B
LSK InvestmentPre Seed
Yuanta InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 6526% from 23 to 1.5K.

  • May 3, 2025

    Monthly visitors increased 73% MoM.

DR.NOAH Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DR.NOAH Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DR.NOAH Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range14
Year Founded2017
Last FundingMay 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?